Foley Partner and chair of the Securities, Commodities & Exchange Regulation Practice George Simon was quoted in an article titled “Unorthodox products get a health warning” in the June 28, 2009 issue of Financial Times. Simon discusses a notice issued by the Financial Industry Regulatory Authority (Finra) stating that inverse and leveraged ETFs typically are not suitable for retail investors who plan to hold them for more than one trading session. Simon remarked that the notice from Finra was stark in its language and may spell the end of the sector.
Related News
July 24, 2025
In the News
Gregory Husisian and David Simon on Tariff Evasion – 'Huge money at stake'
Foley & Lardner LLP partners Gregory Husisian and David Simon detailed the rise and risks of tariff evasion in the POLITICO article, "As Trump raises tariffs, companies find ways to cheat — and risk getting caught."
July 23, 2025
In the News
Aaron Maguregui on AI Scribes in Health Care – 'Technically, it's a third party listening'
Foley & Lardner LLP partner Aaron Maguregui shared insights on the growing applications for artificial intelligence across health care in the healthleaders article, “Is Your AI Scribe HIPAA-Compliant?“
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.